Cancer isn’t just one disease. It is more than 100 diseases, and each of these 100 types can be divided into several sub-types.
The Canadian Cancer Society (CCS) is the only national charity that supports Canadians with all cancers in communities across the country. No other organization does this.
CCS funds ground-breaking research, provides trusted information about cancer, offers programs and services to help people with cancer and their families cope, and advocates to governments for important social change and funding.
When you donate to the Canadian Cancer Society through the Spin For Life fundraising event, you’ll have the option to allocate your donation to any of four key programs.
COVID-19 Cancer Emergency Fund
Since the COVID-19 pandemic was announced by the World Health Organization, the Canadian Cancer Society has made several extraordinary decisions – none of which were ever expected. The CCS has suspended volunteer transportation services, closed lodges and community offices, cancelled or postponed fundraising events, curtailed all in-person contact and laid off a considerable portion of their staff. At the same time, the Canadian Cancer Society has shifted their focus to delivering virtual and online services to the Canadians we serve, while also experiencing a serious decline in donations. Your help is needed now. During this unprecedented time, your generous support will ensure the Canadian Cancer Society can continue to offer critical programs and services to those with cancer, who are quite vulnerable to the virus.
Immunization Clinical Trial
During the pandemic, Canadians with cancer are at a higher risk of serious health outcomes from respiratory infections, such as COVID-19. In a groundbreaking study, researchers are testing a drug (IMM-101) to see if it can reduce the incidence and severity of COVID-19 symptoms in people undergoing cancer treatment. Results from this clinical trial are expected in 6 to 8 months, which is far quicker than most studies of this nature.
The research is being led by the Canadian Cancer Trials Group (CCTG) and Dr Rachel Auer at The Ottawa Hospital, and supported by the Canadian Cancer Society (CCS). The study could inspire scientists to consider IMM-101 as a drug for people with chronic respiratory conditions and compromised immune systems. It could also inform international research teams with data as they develop a vaccine for COVID-19.
A global health crisis does not stop cancer from being a life-altering disease. With stay-at-home measures, Canadians with cancer are experiencing greater anxiety and fear. With physical distancing, they feel lonelier and more isolated. With a compromised immune system, they have a higher risk of serious outcomes from the coronavirus.
Now more than ever, people with cancer are looking to the Canadian Cancer Society (CCS) to find informed answers, express personal worries and voice deep fears. In nearly every call to the toll-free Cancer Information Helpline, Canadians ask about COVID-19 and cancer, and they talk about their distress. To help people in this challenging time, CCS is enhancing its digital and virtual connections to support Canadians with cancer during the pandemic’s uncertainty.
Regional Cancer Research Funds
The Canadian Cancer Society is the largest national charitable funder of cancer research and committed to funding the best cancer research in Canada. Donations to the Cancer Research Fund will support innovative and impactful cancer research conducted in all regions of Canada, as determined by their rigorous expert review process.
- BCY Cancer Research Fund (British Columbia & Yukon)
- Prairies Cancer Research Fund (Alberta, Saskatchewan, Manitoba, & Northwest Territories)
- Ontario Cancer Research Fund
- Quebec Cancer Research Fund
- Atlantic Cancer Research Fund (New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland & Labrador)
Canadian Cancer Trials Group (CCTG)
As a national network of more than 80 member institutions, the Canadian Cancer Trials Group (CCTG) designs and administers clinical trials in cancer therapy, care and prevention. Located in every province, these trials are an essential step in bringing research discoveries from the lab to the people facing cancer. They bring new methods of treatment to patients who need them and give scientists an opportunity to learn how well new treatments or drugs work — all within a well-designed, controlled way.
A founding member of CCTG, the Canadian Cancer Society has provided core funding to its work since 1980. In that time, new cancer drugs, new combinations of treatments and new approaches to prevention and screening have been tested through CCTG-led trials, leading to improved outcomes for Canadians facing cancer.
Travel Treatment Fund & Wheels of Hope
Travel and transportation is one of the largest indirect costs of being diagnosed with cancer. In fact, 1 in 5 Canadians have trouble making it to their cancer treatment appointments. They often bear the burden of long car trips, air travel, fuel and parking, and sometimes, overnight accommodation when their treatment is provided far from home.
Without travel support, financially vulnerable Canadians are at risk of missing medical procedures that could save their lives. Through the Travel Treatment Fund & Wheels of Hope programs, the Canadian Cancer Society provides transportation grants or rides to those who need a lift. Demand for travel support will increase each year as Canada’s population ages and cancer care becomes more specialized and centralized in urban centres.
CCS Wheels of Hope volunteer drivers help lessen the burden of travel to and from treatment for those with physical or financial challenges.